Reverse transcriptase

Reverse transcriptase (RT) is an enzyme used to generate complementary DNA (cDNA) from an RNA template, a process termed reverse transcription. Its discovery fundamentally altered the understanding of molecular biology by demonstrating a permanent exception to the classical Central Dogma of molecular biology, which previously modeled the flow of genetic information strictly as moving from DNA to RNA to proteins.

Discovery

Reverse transcriptase was discovered independently in 1970 by Howard Temin at the University of Wisconsin and David Baltimore at MIT. Both researchers isolated the enzyme from different RNA tumor viruses. For this paradigm-shifting discovery, Temin and Baltimore shared the 1975 Nobel Prize in Physiology or Medicine alongside Renato Dulbecco.

Function in Viruses

Reverse transcriptase is most heavily associated with retroviruses, such as the Human Immunodeficiency Virus (HIV) and the Human T-lymphotropic virus (HTLV).

When a retrovirus infects a target cell, it releases its single-stranded RNA genome into the host's cytoplasm. Because host cells lack the machinery to replicate RNA directly or integrate RNA into their chromosomes, the virus relies on its own pre-packaged reverse transcriptase. The enzyme reads the viral RNA and converts it into a stable, double-stranded DNA molecule. This newly synthesized viral DNA is then transported into the cell nucleus and permanently spliced into the host's genome by the enzyme integrase, establishing a provirus that forces the cell to manufacture new viral particles.

Enzymatic Mechanics

Reverse transcriptase is a multifunctional enzyme that executes three distinct, sequential biochemical activities to convert single-stranded RNA into double-stranded DNA:

1. RNA-dependent DNA polymerase activity: The enzyme reads the viral RNA template and synthesizes a complementary, single-stranded DNA molecule. This process requires a short strand of host tRNA to act as a starting primer. 2. Ribonuclease H (RNase H) activity: Once the RNA-DNA hybrid is formed, the RNase H domain of the enzyme selectively degrades the original RNA template strand, leaving only the newly synthesized single strand of DNA. 3. DNA-dependent DNA polymerase activity: The enzyme then uses the newly made single-stranded DNA as a template to synthesize a second, complementary DNA strand, resulting in a complete double-stranded DNA double helix.

Crucially, viral reverse transcriptase lacks the 3' to 5' exonuclease proofreading capability found in standard cellular DNA polymerase. As a result, it makes frequent transcription errors. This high mutation rate is a primary driver of rapid viral evolution, allowing retroviruses to quickly evade the host's immune system and develop resistance to antiviral medications.

Function in Eukaryotes

While famous for its viral origins, reverse transcription is also essential to normal cellular biology in eukaryotes, including humans:

• Telomerase: The ends of linear chromosomes contain repetitive protective sequences called telomeres, which naturally shorten with each cell division. Telomerase is a specialized ribonucleoprotein complex that acts as a cellular reverse transcriptase. It uses a built-in RNA template to add DNA sequence repeats back onto the chromosome ends, preventing the loss of vital genetic information and playing a key role in cellular aging and cancer immortalization.
• Retrotransposons: A significant portion of the eukaryotic genome consists of mobile genetic elements called retrotransposons (such as Alu elements and LINEs in humans). These "jumping genes" transcribe themselves into RNA, use an internally encoded reverse transcriptase to convert back into DNA, and insert the new copy at a different location in the genome. This copy-and-paste mechanism has been a major engine of genomic expansion and evolutionary change over millions of years.

Applications in Biotechnology

Because of its unique ability to link the transient RNA transcriptome to the stable DNA genome, reverse transcriptase has become an indispensable tool in modern biotechnology and medicine:

• RT-PCR: Reverse transcription polymerase chain reaction (RT-PCR) uses the enzyme to convert fragile messenger RNA (mRNA) into stable cDNA. This allows researchers to accurately measure gene expression levels in tissues or detect the presence of RNA viruses (such as SARS-CoV-2) in patient samples.
• cDNA Libraries: Biologists use the enzyme to construct cDNA libraries. By reverse-transcribing mature mRNA, researchers can isolate the exact protein-coding sequences of genes, completely free of the non-coding introns that clutter the raw genomic DNA.
• Pharmacology: Because RT is essential for retroviral replication but generally not required for day-to-day host cell survival, it is a primary pharmacological target. Reverse transcriptase inhibitors (such as AZT) are the cornerstone of antiretroviral therapy used to manage HIV infections, working by physically blocking the enzyme's active site or prematurely terminating the growing DNA chain.